Literature DB >> 21399661

Overexpression of TRIB2 in human lung cancers contributes to tumorigenesis through downregulation of C/EBPα.

K B Grandinetti1, T A Stevens, S Ha, R J Salamone, J R Walker, J Zhang, S Agarwalla, D G Tenen, E C Peters, V A Reddy.   

Abstract

Lung cancer is the most common cause of cancer-related mortality worldwide. Here, we report elevated expression of tribbles homolog 2 (TRIB2) in primary human lung tumors and in non-small cell lung cancer cells that express low levels of differentiation-inducing transcription factor CCAAT/enhancer-binding protein alpha (C/EBPα). In approximately 10-20% of cases, elevated TRIB2 expression resulted from gene amplification. TRIB2 knockdown was found to inhibit cell proliferation and in vivo tumor growth. In addition, TRIB2 knockdown led to morphological changes similar to C/EBPα overexpression and correlated with increased expression and activity of C/EBPα. TRIB2-mediated regulation of C/EBPα was found to occur through the association of TRIB2 with the E3 ligase TRIM21. Together, these data identify TRIB2 as a potential driver of lung tumorigenesis through a mechanism that involves downregulation of C/EBPα.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21399661      PMCID: PMC3382061          DOI: 10.1038/onc.2011.57

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  41 in total

1.  Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts.

Authors:  Ryusuke Yoshimi; Tsung-Hsien Chang; Hongsheng Wang; Toru Atsumi; Herbert C Morse; Keiko Ozato
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

2.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

3.  Human TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of melanoma cells.

Authors:  F Zanella; O Renner; B García; S Callejas; A Dopazo; S Peregrina; A Carnero; W Link
Journal:  Oncogene       Date:  2010-03-08       Impact factor: 9.867

4.  Differential ability of Tribbles family members to promote degradation of C/EBPalpha and induce acute myelogenous leukemia.

Authors:  Priya H Dedhia; Karen Keeshan; Sacha Uljon; Lanwei Xu; Maria E Vega; Olga Shestova; Meirav Zaks-Zilberman; Candice Romany; Stephen C Blacklow; Warren S Pear
Journal:  Blood       Date:  2010-04-21       Impact factor: 22.113

Review 5.  Dysregulation of the C/EBPalpha differentiation pathway in human cancer.

Authors:  Steffen Koschmieder; Balazs Halmos; Elena Levantini; Daniel G Tenen
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

6.  Identification of cells initiating human melanomas.

Authors:  Tobias Schatton; George F Murphy; Natasha Y Frank; Kazuhiro Yamaura; Ana Maria Waaga-Gasser; Martin Gasser; Qian Zhan; Stefan Jordan; Lyn M Duncan; Carsten Weishaupt; Robert C Fuhlbrigge; Thomas S Kupper; Mohamed H Sayegh; Markus H Frank
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962

7.  Ro52-mediated monoubiquitination of IKK{beta} down-regulates NF-{kappa}B signalling.

Authors:  Keiji Wada; Motoko Niida; Makoto Tanaka; Tetsu Kamitani
Journal:  J Biochem       Date:  2009-08-12       Impact factor: 3.387

8.  Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

Authors:  Matilde Todaro; Mileidys Perez Alea; Anna B Di Stefano; Patrizia Cammareri; Louis Vermeulen; Flora Iovino; Claudio Tripodo; Antonio Russo; Gaspare Gulotta; Jan Paul Medema; Giorgio Stassi
Journal:  Cell Stem Cell       Date:  2007-10-11       Impact factor: 24.633

9.  Dual-promoter lentiviral system allows inducible expression of noxious proteins in macrophages.

Authors:  Hui Pan; Gustavo Mostoslavsky; Evgeny Eruslanov; Darrell N Kotton; Igor Kramnik
Journal:  J Immunol Methods       Date:  2007-10-18       Impact factor: 2.303

10.  Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase.

Authors:  Subbareddy Maddika; Junjie Chen
Journal:  Nat Cell Biol       Date:  2009-03-15       Impact factor: 28.824

View more
  42 in total

1.  E2/Estrogen receptor/sjogren syndrome-associated autoantigen relieves coactivator activator-induced G1/S arrest to promote breast tumorigenicity.

Authors:  Yun Kyoung Kang; Sung Yun Jung; Jun Qin; Chao Li; Sophia Y Tsai; Ming-Jer Tsai; Bert W O'Malley
Journal:  Mol Cell Biol       Date:  2014-02-24       Impact factor: 4.272

Review 2.  A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood.

Authors:  A R Lourenço; P J Coffer
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

3.  The Tribbles 2 (TRB2) pseudokinase binds to ATP and autophosphorylates in a metal-independent manner.

Authors:  Fiona P Bailey; Dominic P Byrne; Krishnadev Oruganty; Claire E Eyers; Christopher J Novotny; Kevan M Shokat; Natarajan Kannan; Patrick A Eyers
Journal:  Biochem J       Date:  2015-04-01       Impact factor: 3.857

4.  Upregulation of TRIB2 by Wnt/β-catenin activation in BRAFV600E papillary thyroid carcinoma cells confers resistance to BRAF inhibitor vemurafenib.

Authors:  Nianxue Wang; Jing Wen; Wei Ren; Yuting Wu; Chaonan Deng
Journal:  Cancer Chemother Pharmacol       Date:  2021-04-16       Impact factor: 3.333

5.  The presence of C/EBPα and its degradation are both required for TRIB2-mediated leukaemia.

Authors:  C O'Connor; F Lohan; J Campos; E Ohlsson; M Salomè; C Forde; R Artschwager; R M Liskamp; M R Cahill; P A Kiely; B Porse; K Keeshan
Journal:  Oncogene       Date:  2016-03-21       Impact factor: 9.867

6.  TRIB2 acts downstream of Wnt/TCF in liver cancer cells to regulate YAP and C/EBPα function.

Authors:  Jiayi Wang; Joo-Seop Park; Yingying Wei; Mihir Rajurkar; Jennifer L Cotton; Qishi Fan; Brian C Lewis; Hongkai Ji; Junhao Mao
Journal:  Mol Cell       Date:  2013-06-13       Impact factor: 17.970

7.  Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells.

Authors:  Daniel M Foulkes; Dominic P Byrne; Wayland Yeung; Safal Shrestha; Fiona P Bailey; Samantha Ferries; Claire E Eyers; Karen Keeshan; Carrow Wells; David H Drewry; William J Zuercher; Natarajan Kannan; Patrick A Eyers
Journal:  Sci Signal       Date:  2018-09-25       Impact factor: 8.192

8.  Impaired phosphorylation and ubiquitination by p70 S6 kinase (p70S6K) and Smad ubiquitination regulatory factor 1 (Smurf1) promote tribbles homolog 2 (TRIB2) stability and carcinogenic property in liver cancer.

Authors:  Jiayi Wang; Yue Zhang; Wenhao Weng; Yongxia Qiao; Lifang Ma; Weifan Xiao; Yongchun Yu; Qiuhui Pan; Fenyong Sun
Journal:  J Biol Chem       Date:  2013-10-02       Impact factor: 5.157

9.  Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.

Authors:  László Bányai; Maria Trexler; Krisztina Kerekes; Orsolya Csuka; László Patthy
Journal:  Elife       Date:  2021-01-11       Impact factor: 8.140

10.  Long noncoding RNA TUG1 regulates the progression of colorectal cancer through miR-542-3p/TRIB2 axis and Wnt/β-catenin pathway.

Authors:  Quanlin Liu; Wei Zhang; Linshan Luo; Keshun Han; Ruitao Liu; Shue Wei; Xiaoran Guo
Journal:  Diagn Pathol       Date:  2021-05-24       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.